Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 19, Number 3—March 2013

Synopsis

Human Leptospirosis Trends, the Netherlands, 1925–2008

Marga G.A. GorisComments to Author , Kimberly R. Boer, Tamara A.T.E. Duarte, Suzanne J. Kliffen, and Rudy A. Hartskeerl
Author affiliations: Author affiliation: Royal Tropical Institute (KIT), Amsterdam, the Netherlands

Main Article

Table 3

Treatment course and deaths, by infecting Leptospira spp. serogroups, for case-patients with leptospirosis, the Netherlands, 1925–2008*

Serogroup No. patients No. (%) hospitalized No. (%) treated with dialysis No. (%) treated in ICU No (%) died
Icterohaemorrhagiae 1,702 1,311 (77.0) 90 (11.9) 68 (7.0) 90 (5.3)
Grippotyphosa 196 124 (63.3) 3 (2.2) 2 (1.2) 0
Sejroe 128 48 (37.5) 3 (2.4) 2 (1.6) 1 (0.8)
Canicola 93 60 (64.5) 0 0 (0.0) 3 (3.2)
Pomona 54 40 (74.1) 3 (5.6) 7 (13.0) 0
Other 81 55 (67.9) 3 (3.8) 6 (7.6) 1 (1.9)
Unknown 299 213 (71.2) 17 (8.6) 21 (9.3) 71 (23.7)

*ICU, intensive care unit. Data were available for 2,553 patients who were hospitalized or died, 1,360 patients treated with dialysis, and 1,641 patients treated in an ICU.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO